New Issue: Amgen sells $1 billion of 3.2% 10-year senior notes at 87.5 bps spread

By Cristal Cody

Tupelo, Miss., Oct. 31 – Amgen Inc. sold $1 billion of 3.2% 10-year senior notes (Baa1/A) on Tuesday at a spread of 87.5 basis points over Treasuries, according to an FWP filing with the Securities and Exchange Commission.

The notes priced at 99.601 to yield 3.247%.

J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, BNP Paribas Securities Corp., RBC Capital Markets, LLC and UBS Securities LLC were the bookrunners.

Proceeds will be used for general corporate purposes.

Amgen is a Thousand Oaks, Calif., manufacturer and marketer of human therapeutics based upon advances in cellular and molecular biology.

Issuer:	Amgen Inc.
Amount:	$1 billion
Description:	Senior notes
Maturity:	Nov. 2, 2027
Bookrunners:	J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, BNP Paribas Securities Corp., RBC Capital Markets, LLC and UBS Securities LLC
Co-managers:	Barclays, Citigroup Global Markets Inc., Credit Suisse Securities (USA) LLC, Deutsche Bank Securities Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc., Mizuho Securities USA LLC, BofA Merrill Lynch, MUFG, SMBC Nikko Securities America, Inc., Wells Fargo Securities, LLC and Academy Securities, Inc.
Coupon:	3.2%
Price:	99.601
Yield:	3.247%
Spread:	Treasuries plus 87.5 bps
Trade date:	Oct. 31
Settlement date:	Nov. 2
Ratings:	Moody’s: Baa1
	S&P: A
Distribution:	SEC registered

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.